When Randy Hillard was diagnosed with metastatic stomach cancer in 2010 he was treated with a drug that increased overall survival to an average of 13 months. Now, nearly 5 years later, his unexpected survival has led to some unexpected issues.
Jeffrey Meyerhardt, MD, shares research highlights from the 2015 ASCO Annual Meeting on gastrointestinal cancers.
Connecting with others who know exactly what you are going through provides much-needed support for many people with cancer. Randy Hillard, MD, talks about how joining (and now administrating) an online group for people with stomach cancer offers so much more than support.
Learn about the latest advances in the treatment of colorectal cancer, pancreatic cancer, stomach cancer, and neuroendocrine tumors.